Design Therapeutics DSGN
NASDAQ DSGN
$12.34 +0.10 (+0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Design Therapeutics' Return on Capital Employed [ROCE] was -37.52% in Q2 2026, down 3.68 percentage points from -33.84% a year earlier and down 1.41 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Design Therapeutics came in at -35.15%, down 11.37 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of -17.94 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -23.77% in FY2024 (+1.80 pp), -25.57% in FY2023 (-6.54 pp), -19.04% in FY2022 (-1.83 pp) and -17.21% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -38.59% (Q4 2025) and -7.19% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for six straight quarters, with an average year-over-year change of -5.66 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2024 (a gain of 4.56 percentage points); the worst was Q3 2025 (a drop of 14.28 percentage points).
  • Per Business Quant data, DSGN's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -36.10% (Q1 2026), -38.59% (Q4 2025) and -37.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Design Therapeutics 772.24 Mn -83.80 Mn - -37.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.52%
Mar 31, 2026 -36.10%
Dec 31, 2025 -38.59%
Sep 30, 2025 -37.83%
Jun 30, 2025 -33.84%
Mar 31, 2025 -28.92%
Dec 31, 2024 -25.11%
Sep 30, 2024 -23.55%
Jun 30, 2024 -23.67%
Mar 31, 2024 -25.60%
Dec 31, 2023 -27.42%
Sep 30, 2023 -28.11%
Jun 30, 2023 -27.06%
Mar 31, 2023 -23.43%
Dec 31, 2022 -20.05%
Sep 30, 2022 -16.91%
Jun 30, 2022 -14.06%
Mar 31, 2022 -11.48%
Dec 31, 2021 -9.18%
Sep 30, 2021 -7.19%
API Access

Design Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DSGN&period=max&api_key=YOUR_API_KEY